Patients with MDR-TB/HIV coinfection should be provided with early diagnosis, timely access to second-line anti-TB drugs, motivational counseling, and early ART, as soon as MDR-TB treatment is tolerated, regardless of CD4 count [13, 40]. This evidence concerns the gene CD4 and coinfection.